Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Therapy
Study data from University of Nottingham update knowledge of hepatitis C virus therapy
August 6th, 2007
Researchers detail in "Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study," new data in hepatitis C virus. "We analysed the Trent Hepatitis C cohort to determine standardised mortality ratios in patients infected with hepatitis C virus (HCV), and to identify risk factors and associations with all-cause and liver-related mortality. Cohort study. Patients with HCV infection attending secondary care within the Trent region of U.K.. 2285 patients with hepatitis C, followed for 1 year or more. The death rate in the cohort was compared to that seen in an age-and sex-matched English population," investigators in the United Kingdom...
Source: Hepatitis Weekly (2007-08-06)
|
